Details of the Drug-Related molecule(s) Interaction Atlas

General Information of Drug (ID: DMWJMFZ)

Drug Name

Miravirsen Drug Info

Synonyms

Miravirsen; Miravirsen [INN]; SPC3649 Parent Acid; UNII-Q083AJW7VS; Q083AJW7VS; 1072874-90-8; RNA, (P-thio)((2'-O,4'-C-methylene)m5C-dC-(2'-O,4'-C-methylene)A-dT-dT-(2'-O,4'-C-methylene)G-(2'-O,4'-C-methylene)m5U-dC-dA-(2'-O,4'-C-methylene)m5C-dA-(2'-O,4'-C-methylene)m5C-dT-(2'-O,4'-C-methylene)m5C-(2'-O,4'-C-methylene)m5C)

Indication

Disease Entry	ICD 11	Status	REF
Hepatitis C virus infection	1E51.1	Phase 2	[1]

Cross-matching ID

PubChem CID: 56843415
CAS Number: CAS 1072874-90-8
TTD Drug ID: DMWJMFZ

Molecule-Related Drug Atlas

Molecule Type:

DTT

Drug Status:

Clinical Trial Drug(s)

Download the Complete Related Drug List

Drug(s) Targeting Hepatitis C virus microRNA miR-122 (HCV MIR122)

Drug Name	Drug ID	Indication	ICD 11	Highest Status	REF
RG-101	DM2UGT7	Hepatitis C virus infection	1E51.1	Phase 2	[3]
------------------------------------------------------------------------------------

Molecular Interaction Atlas of This Drug

Molecular Interaction Atlas

Download the Complete Interaction Atlas for Visualization in Cytoscape

Drug Therapeutic Target (DTT)

DTT Name	DTT ID	UniProt ID	MOA	REF
Hepatitis C virus microRNA miR-122 (HCV MIR122)	TTP03CE	NOUNIPROTAC	Modulator	[2]

------------------------------------------------------------------------------------

References

1	2011 Pipeline of Santaris Pharma.
2	Miravirsen (SPC3649) can inhibit the biogenesis of miR-122.Nucleic Acids Res.2014 Jan;42(1):609-21.
3	Company report (Isis Pharmaceuticals)